(MENAFN- Ameliorate Digital Consultancy)
The artificial saliva market had a total revenue of US$667.9 Mn. By 2026, the market is anticipated to have grown at a CAGR of 13.3%, valuing itself at US$ 1.4 billion. The artificial saliva market refers to the market for synthetic formulations designed to mimic the properties and functions of natural saliva. These formulations are typically used to treat conditions such as dry mouth or xerostomia, which can be caused by a variety of factors, including medication use, radiation therapy, autoimmune disorders, and aging.
The global market for artificial saliva is expected to experience significant growth in the coming years, driven by increasing prevalence of xerostomia and a growing aging population. In addition, the development of new formulations and delivery methods is also expected to drive market growth.
Download Free Sample Copy of this Report –
Key Segments Covered in Artificial Saliva Industry Research
Artificial Saliva Market by Product : Oral Sprays Oral Solutions Oral Liquids Gels Powders
Artificial Saliva Market by Age Group : Artificial Saliva Market by Distribution Channel : Hospital Pharmacies Retail Pharmacies Mail Order Pharmacies Hypermarkets and Supermarkets
Artificial Saliva Treatment Market by Region : North America Artificial Saliva Market Europe Artificial Saliva Market Asia Pacific Artificial Saliva Market Latin America Artificial Saliva Market MEA Artificial Saliva Market
Key Takeaways from Market Study
Global artificial saliva market to reach US$ 1.4 Bn valuation by 2026. Oral sprays expected to reach around US$ 579.2 Mn by 2026-end. Oral solutions projected to record 12.6% CAGR from 2021 to 2026 Market in Europe to record 9.6% CAGR over forecast period (2022-2026).
Get Customization on this Report for Specific Research Solutions –
Winning Strategy
Key manufacturers of artificial saliva are concentrating on growing their product portfolios, acquiring up-and-coming competitors, and signing distribution agreements in order to increase their regional presence. Key suppliers are focusing on diversifying their portfolios to survive in this environment because artificial saliva products are in higher demand.
Major players are concentrating on acquiring new companies and launching campaigns to increase awareness of conditions that cause dry mouth. Because consumers are more likely to purchase goods from well-known businesses, major players are focusing on enhancing their brands.
For instance,
For those who experience xerostomia and dysphagia, ICPA Health Products (ICPA) introduced Wet Mouth in September 2021 as an alternative to saliva.
Key Companies Profiled
Bausch Health Companies Inc. Cipla Ltd. Mission Pharmacal Company GlaxoSmithKline PLC ICPA Health Pvt. Ltd. Forward Science Fresenius Kabi AG Midatech Pharma PLC Perrigo Company PLC
Regional Analysis For Artificial Saliva Market
APAC (Japan, China, South Korea, Australia, India, and the rest of APAC; the rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) North America (USA, Canada and Mexico) South America (Brazil, Chile, Argentina, Rest of South America) MEA (Saudi Arabia, United Arab Emirates, South Africa)
Key Questions Covered in the Artificial Saliva Market
What are the key drivers of growth in the artificial saliva market? What are the major challenges facing the market, and how are companies addressing these challenges? What are the major types of artificial saliva formulations available in the market, and how do they compare in terms of efficacy and patient preferences? What are the major applications of artificial saliva, and what are the key therapeutic areas in which these formulations are used? Who are the major players in the artificial saliva market, and what are their market shares and competitive strategies? For in-depth competitive analysis, Buy Now –
Overall, the artificial saliva market is expected to continue to grow in the coming years, driven by a combination of factors including increasing prevalence of xerostomia, expanding treatment options, and growing awareness of the condition among both patients and healthcare providers.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
MENAFN23032023004660010643ID1105848897
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.